Sanofi (NASDAQ:SNY) Stock Position Raised by Gallacher Capital Management LLC

Gallacher Capital Management LLC boosted its holdings in Sanofi (NASDAQ:SNY) by 14.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,686 shares of the company’s stock after acquiring an additional 843 shares during the period. Gallacher Capital Management LLC’s holdings in Sanofi were worth $325,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Rise Advisors LLC boosted its stake in Sanofi by 98.4% during the 4th quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. Salem Investment Counselors Inc. acquired a new position in shares of Sanofi during the fourth quarter worth approximately $27,000. Venturi Wealth Management LLC grew its holdings in Sanofi by 163.5% in the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after buying an additional 332 shares in the last quarter. Frazier Financial Advisors LLC acquired a new stake in Sanofi in the 4th quarter valued at approximately $28,000. Finally, Register Financial Advisors LLC bought a new stake in Sanofi during the 1st quarter valued at $29,000. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Price Performance

NASDAQ:SNY traded up $0.26 during midday trading on Friday, hitting $51.47. 497,743 shares of the stock were exchanged, compared to its average volume of 2,131,610. The company has a market capitalization of $130.36 billion, a price-to-earnings ratio of 25.73, a P/E/G ratio of 1.58 and a beta of 0.59. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. Sanofi has a one year low of $42.63 and a one year high of $55.72. The business has a 50-day moving average price of $48.84 and a two-hundred day moving average price of $48.64.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, April 25th. The company reported $0.96 EPS for the quarter, hitting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The firm had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Sell-side analysts predict that Sanofi will post 4.14 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.